Functional complementation of the envelope hypervariable V3 loop of human immunodeficiency virus type 1 subtype B by the subtype E V3 loop

被引:17
作者
Sato, H [1 ]
Kato, K [1 ]
Takebe, Y [1 ]
机构
[1] Natl Inst Infect Dis, Ctr AIDS Res, Lab Mol Virol & Epidemiol, Tokyo 1628640, Japan
关键词
D O I
10.1006/viro.1999.9670
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The hypervariable V3 loop within gp120 of human immunodeficiency virus type 1 (HIV-1) is the major determinant of cell tropism and the entry coreceptor usage of the virus. However, the information obtained thus far has been from only subtype B from North America and Europe, and little is known about other subtypes whose V3 amino acids differ by as much as 50% from subtype B vs. In this study, we examined the functional potential of the Vs element of the HIV-1 subtype E, the most crucial variant causing the AIDS epidemic throughout southeast Asia. A panel of HIV-1(LAI) recombinants was constructed by the overlap extension method, by which the LAI V3 loop was precisely replaced by that of the subtype E nonsyncytium-inducing (NSI) or syncytium-inducing (SI) variant. All of the recombinant viruses infected peripheral blood mononuclear cells, whereas only those with SI V3 infected MT2 cells, a CD4(+) T cell line. Consistently, the SI V3 recombinants used CXCR4, while the NSI V3 recombinants used CCR5 for infection of HOS-CD4(+) cells. Finally, only the NSI V3 sequence conferred CC-chemokine sensitivity on the parental virus. The data support the notion that the HIV-1 V3 loop consists of a relatively independent domain in gp120 and suggest that the subtype E V3 loop indeed contains the functional element to dictate the cell tropism, coreceptor preference, and chemokine sensitivity of the virus. These findings are of immediate importance in understanding V3 structure-function relationship and for examining phenotypic evolution of HIV-I subtype E. (C) 1999 Academic Press.
引用
收藏
页码:491 / 501
页数:11
相关论文
共 64 条
[11]   IDENTIFICATION OF RANTES, MIP-1-ALPHA, AND MIP-1-BETA AS THE MAJOR HIV-SUPPRESSIVE FACTORS PRODUCED BY CD8(+) T-CELLS [J].
COCCHI, F ;
DEVICO, AL ;
GARZINODEMO, A ;
ARYA, SK ;
GALLO, RC ;
LUSSO, P .
SCIENCE, 1995, 270 (5243) :1811-1815
[12]   The V3 domain of the HIV-1 gp120 envelope glycoprotein is critical for chemokine-mediated blockade of infection [J].
Cocchi, F ;
DeVico, AL ;
GarzinoDemo, A ;
Cara, A ;
Gallo, RC ;
Lusso, P .
NATURE MEDICINE, 1996, 2 (11) :1244-1247
[13]   Change in coreceptor use correlates with disease progression in HIV-1-infected individuals [J].
Connor, RI ;
Sheridan, KE ;
Ceradini, D ;
Choe, S ;
Landau, NR .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (04) :621-628
[14]   HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 CLONES CHIMERIC FOR THE ENVELOPE V3 DOMAIN DIFFER IN SYNCYTIUM FORMATION AND REPLICATION CAPACITY [J].
DEJONG, JJ ;
GOUDSMIT, J ;
KEULEN, W ;
KLAVER, B ;
KRONE, W ;
TERSMETTE, M ;
DERONDE, A .
JOURNAL OF VIROLOGY, 1992, 66 (02) :757-765
[15]   MINIMAL REQUIREMENTS FOR THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 V3 DOMAIN TO SUPPORT THE SYNCYTIUM-INDUCING PHENOTYPE - ANALYSIS BY SINGLE AMINO-ACID SUBSTITUTION [J].
DEJONG, JJ ;
DERONDE, A ;
KEULEN, W ;
TERSMETTE, M ;
GOUDSMIT, J .
JOURNAL OF VIROLOGY, 1992, 66 (11) :6777-6780
[16]   Identification of a major co-receptor for primary isolates of HIV-1 [J].
Deng, HK ;
Liu, R ;
Ellmeier, W ;
Choe, S ;
Unutmaz, D ;
Burkhart, M ;
DiMarzio, P ;
Marmon, S ;
Sutton, RE ;
Hill, CM ;
Davis, CB ;
Peiper, SC ;
Schall, TJ ;
Littman, DR ;
Landau, NR .
NATURE, 1996, 381 (6584) :661-666
[17]   SYNCYTIUM-INDUCING AND NON-SYNCYTIUM-INDUCING CAPACITY OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 SUBTYPES OTHER THAN B - PHENOTYPIC AND GENOTYPIC CHARACTERISTICS [J].
DEWOLF, F ;
HOGERVORST, E ;
GOUDSMIT, J ;
FENYO, EM ;
RUBSAMENWAIGMANN, H ;
HOLMES, H ;
GALVAOCASTRO, B ;
KARITA, E ;
WASI, C ;
SEMPALA, SDK ;
BAAN, E ;
ZORGDRAGER, F ;
LUKASHOV, V ;
OSMANOV, S ;
KUIKEN, C ;
CORNELISSEN, M ;
BELSEY, EM ;
HEYWARD, W ;
ESPARZA, J ;
VANDEPERRE, P ;
SEMPALA, S ;
TUGUME, B ;
BIRYAHWAHO, B ;
VONBRIESEN, H ;
ESSER, R ;
GREZ, M ;
NEWBERRY, A ;
RANJBAR, S ;
TOMLINSON, P ;
BRADAC, J ;
MCCUTCHAN, F ;
LOUWAGIE, J ;
HEGERICH, P ;
LOPEZGALINDEZ, C ;
OLIVARES, I ;
DOPAZO, J ;
MULLINS, JI ;
DELWART, EL ;
BACHMANN, HM ;
HAHN, BH ;
GAO, F ;
YUE, L ;
SARAGOSTI, S ;
SCHOCHETMAN, G ;
KALISH, M ;
LUO, CC ;
GEORGE, R ;
PAU, CP ;
WEBER, J ;
CHEINGSONGPOPOV, R .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1994, 10 (11) :1387-1400
[18]   Langerhans cell tropism of human immunodeficiency virus type 1 subtype A through F isolates derived from different transmission groups [J].
Dittmar, MT ;
Simmons, G ;
Hibbitts, S ;
OHare, M ;
Louisirirotchanakul, S ;
Beddows, S ;
Weber, J ;
Clapham, PR ;
Weiss, RA .
JOURNAL OF VIROLOGY, 1997, 71 (10) :8008-8013
[19]   HIV-1 entry into CD4(+) cells is mediated by the chemokine receptor CC-CKR-5 [J].
Dragic, T ;
Litwin, V ;
Allaway, GP ;
Martin, SR ;
Huang, YX ;
Nagashima, KA ;
Cayanan, C ;
Maddon, PJ ;
Koup, RA ;
Moore, JP ;
Paxton, WA .
NATURE, 1996, 381 (6584) :667-673
[20]   Amino-terminal substitutions in the CCR5 coreceptor impair gp120 binding and human immunodeficiency virus type 1 entry [J].
Dragic, T ;
Trkola, A ;
Lin, SW ;
Nagashima, KA ;
Kajumo, F ;
Zhao, L ;
Olson, WC ;
Wu, LJ ;
Mackay, CR ;
Allaway, GP ;
Sakmar, TP ;
Moore, JP ;
Maddon, PJ .
JOURNAL OF VIROLOGY, 1998, 72 (01) :279-285